What drives research in the field of biomaterials?

by Guest | Apr 22, 2015

. By Hamideh Emrani It always feels amazing to find a solution to a problem or challenge. I think this huge sense of accomplishment is what drives many people in the research community. During my academic career, I have come across some remarkable scientists and...

Right Turn: Imagination according to GE

by Stacey Johnson | Apr 17, 2015

. This week, General Electric (GE) announced that it is creating a six-part documentary series about science and technology that will be broadcast on the National Geographic Channel beginning in November. According to the New York Times, the series will focus on the...

ISSCR takes a pre-emptive stand on ethical issues

by David Kent | Apr 16, 2015

. Last month, Nature published a comment by Edward Lanphier and colleagues, which foreshadows the publication of a study in which scientists have used new genome editing tools to modify the DNA of human embryos. Author David Cyranoski weighed in, suggesting that...

Regenerative Medicine Deal Review: March

by Mark Curtis | Apr 13, 2015

. Welcome to your deal review for the month of March. Cellular Dynamics threw shareholders for a loop after making a seemingly hasty decision to sell the company off to Fujifilm in a $307* million deal. Merck and synthetic biology specialist Intrexon announced a...

Right Turn: He wants a clone

by Stacey Johnson | Apr 10, 2015

. Who doesn’t love a science lesson communicated through song? (That’s rhetorical; there’s no need to leave a comment below.) Mr. W., aka Glenn Wolkenfeld, has been educating and enthralling high school students and ended up with a teaching...

Update from the Clinic: March

by Mark Curtis | Apr 7, 2015

. Welcome to your Update from the Clinic for the month of March. Investors weren’t so keen on Neuralstem’s topline results in amyotropic lateral sclerosis (ALS). NeoStem’s follow-up data from its PreSERVE study in acute myocardial infarction (AMI) was somewhat...

Right Turn: StemCellTalks in Tweets

by Stacey Johnson | Apr 3, 2015

. Last month (March 13), StemCellTalks held a symposium on diabetes and stem cell tourism to educate Toronto high school students about the field. (These events happen across Canada.) The morning session began with Dr. Elia Piccinini (University of Toronto) giving an...

If it ain’t broke….Farewell and thanks to the Stem Cell Network

by Stacey Johnson | Mar 31, 2015

. In May 2012, the Stem Cell Network (SCN) and the Centre for Commercialization of Regenerative Medicine (CCRM) launched Signals Blog, an evolution of SCN’s popular Stem Cell Network Blog and the brainchild of Lisa Willemse, Director of Communications at SCN. Beyond...

Right Turn: End of an era, almost

by Lisa Willemse | Mar 27, 2015

> This is my final post as co-editor of Signals, and in sitting down to draft it, I found myself struggling to find words. How do you sum up six years of blogging? Quite simply, you don’t. However, as this also marks the end of the Stem Cell Network’s involvement...

Update from the Clinic: February

by Mark Curtis | Mar 25, 2015

. Welcome to your Update from the Clinic for the month of February. Northwest Biotherapeutics received approval from Health Canada to proceed with its ongoing Phase 3 clinical study in Glioblastoma multiforme at clinical sites in Quebec. Sangamo and bluebird bio both...